TWST logo

TWST
Twist Bioscience Corp

4,122
Mkt Cap
$3.34B
Volume
954,541.00
52W High
$66.06
52W Low
$23.30
PE Ratio
-40.39
TWST Fundamentals
Price
$58.61
Prev Close
$53.66
Open
$53.29
50D MA
$52.45
Beta
2.30
Avg. Volume
1.26M
EPS (Annual)
-$1.30
P/B
7.33
Rev/Employee
$384,649.64
$1,526.14
Loading...
Loading...
News
all
press releases
Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results
Twist Bioscience Corporation (TWST) Announces Q2 2026 Financial Results...
Yahoo! Finance: News·11d ago
News Placeholder
More News
News Placeholder
These Analysts Boost Their Forecasts On Twist Bioscience After Q2 Results
Twist Bioscience Corp (TWST) reported Q2 loss but exceeded sales guidance. CEO expects profitability and raised FY sales guidance. Analysts raise price targets.read more...
Benzinga·16d ago
News Placeholder
Company News for May 5, 2026
Companies in The News Are: TSN,TWST,EBAY,GME,XOM
Zacks·16d ago
News Placeholder
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
As required by the rules of the Nasdaq Stock Market, Twist Bioscience Corporation (NASDAQ: TWST) (Twist or the Company), a mid-cap growth and value biotech company, today announced that a total of...
Business Wire·16d ago
News Placeholder
AI-Driven Demand Boosts Twist Bioscience Sales, But Loss Widens
Twist Bioscience posts wider Q2 loss, beats revenue estimates, raises FY26 outlook, and expands gene portfolio.read more...
Benzinga·17d ago
News Placeholder
Twist Bioscience (NASDAQ:TWST) Stock Price Down 5.3% on Disappointing Earnings
Twist Bioscience (NASDAQ:TWST) Shares Down 5.3% on Disappointing Earnings...
MarketBeat·17d ago
News Placeholder
Twist Bioscience (NASDAQ:TWST) Issues Quarterly Earnings Results, Misses Expectations By $0.17 EPS
Twist Bioscience (NASDAQ:TWST - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.71) EPS for the quarter, missing analysts' consensus estimates of ($0.54) by...
MarketBeat·17d ago
News Placeholder
Twist Bioscience Q2 Earnings Call Highlights
Twist Bioscience (NASDAQ:TWST) reported fiscal 2026 second-quarter results that management said extended a streak of steady execution, highlighted by its 13th consecutive quarter of sequential revenue growth and gross margin above 50%. On the company's earnings call, CEO and co-founder Dr. Emily Le...
MarketBeat·17d ago
News Placeholder
Twist Bioscience Q2 2026 Earnings Call Transcript
read more...
Benzinga·17d ago
News Placeholder
Twist Bioscience (TWST) Reports Q2 Loss, Beats Revenue Estimates
Twist Bioscience (TWST) delivered earnings and revenue surprises of -14.82% and +2.68%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·17d ago
<
1
2
...
>

Latest TWST News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.